Oxolife SL Company
Oxolife is a small-sized clinical-stage biotech company focused and committed to female fertility improvement. The company is developing a first-in-class drug acting directly on the endometrium enhancing embryo implantation and increasing Life Birth Rates.
Industry:
Reproductive Health & Contraception
Headquarters:
Barcelona, Spain
Founded Date:
18-01-2013
Employees Number:
1-10
Investors Number:
1
Total Funding:
$10,000,000
Estimated Revenue:
Pre-revenue
Last Funding Date:
2021-01-28
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership